Comment on: A relapse of Guillain-Barre syndrome caused by SARS-CoV-2 is not uncommon
Neurosciences (Riyadh)
.
2024 Jan;29(1):65-66.
doi: 10.17712/nsj.2024.1.20230104.
Authors
Sounira Mehri
1
,
Josef Finsterer
2
,
Vladimir S Jankovic
3
Affiliations
1
Biochemistry Laboratory, LR12ES05 "Nutrition-Functional Foods and Vascular Health", Faculty of Medicine, Monastir, Tunisia.
2
Neurology & Neurophysiology Center, Vienna, Austria.
3
Department of Neurology, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.
PMID:
38195132
PMCID:
PMC10827021
DOI:
10.17712/nsj.2024.1.20230104
No abstract available
Publication types
Comment
MeSH terms
COVID-19* / complications
Guillain-Barre Syndrome* / etiology
Humans
Recurrence
SARS-CoV-2